Grant W. Cannon

Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes

Mark C. Genovese, Joan M. Bathon, Richard W. Martin et al. · Arthritis & Rheumatism · 2002 · 731 citations

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study

Daniel O. Clegg, Domenic J. Reda, Edwin Mejías et al. · Arthritis & Rheumatism · 1996 · 444 citations

Periodontitis and <i>Porphyromonas gingivalis</i> in Patients With Rheumatoid Arthritis

Ted R. Mikuls, Jeffrey B. Payne, Fang Yu et al. · Arthritis & Rheumatology · 2014 · 367 citations · Full text

Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate

Stanley Cohen, Grant W. Cannon, Michael Schiff et al. · Arthritis & Rheumatism · 2001 · 297 citations

Rheumatoid Disorder, Rheumatology, Active Ra +11

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

Grant W. Cannon, Jacques R. Caldwell, Peter R. Holt et al. · Arthritis & Rheumatism · 2000 · 279 citations